Rising Demand for Heart Failure Therapeutics Market Key Players, Growth Analysis during 2022-2028
The global heart failure therapeutics market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Heart failure is a medical condition caused due to abnormal cardiac structure and function. Heart failure is a chronic progressive disorder that affects the blood pumping capacity of the heart muscles, leading to an insufficient supply of blood to the whole body. Heart failure has a significant burden on the global healthcare system, affecting more than 26 million people across the globe. It is estimated that heart failure across the globe had cost around $100 billion in 2012. Among these, the growing global population suffering from cardiovascular illnesses is the primary factor for the increased market growth.
To Request a Sample of our Report on Heart Failure
Therapeutics Market: https://www.omrglobal.com/request-sample/heart-failure-therapeutics-market
Globally, almost 15 million people suffer from
heart attacks or similar issues, according to the World Heart Federation. Six
million of these patients will die, while another five million will be severely
crippled. In the US, one person dies from CVD every 36 seconds. Heart disease
claims the lives of around 659,000 people in the US each year, accounting for
one out of every four mortalities. Between 2016 and 2017, the US spent $363
billion on heart disease. This covers the costs of healthcare services,
medications, and lost productivity as a result of mortality. The most frequent
type of heart illness, coronary heart disease, killed 360,900 people in 2019.
These diseases affect approximately 18.2 million persons aged 20 and up (about
6.7%). Adults under the age of 65 account for about 2 out of every 10
mortalities due to coronary artery disease. This results in the rising
incidences of heart failure, which in turn, is driving the growth of the global
heart failure therapeutics market.
Market Coverage
·
The market number available for – 2021-2028
·
Base year- 2021
·
Forecast period- 2022-2028
Segment Covered-
·
By Heart Failure Stage
·
By Drug Class
·
By Distribution Channel
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape: Amgen Inc., Johnson & Johnson Services,
Inc., and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Heart Failure Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/heart-failure-therapeutics-market
Global Heart Failure Therapeutics Market Report by Segment
By Heart Failure Stage
·
Class I
·
Class II
·
Class III
·
Class IV
By Drug Class
·
Angiotensin-Converting Enzyme Inhibitors
·
Angiotensin Receptor Blockers
·
Diuretics
·
Beta Blockers
·
Procoralan
·
Mineralocorticoid Receptor Antagonists
·
Others
By Distribution Channel
·
Hospital Pharmacy
·
Retail Pharmacy
·
Online Pharmacy
Global Heart Failure Therapeutics Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment